The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Factors influencing disease control in metastatic lung cancer with intracranial metastasis post gamma-knife radiotherapy.
 
Laura Tam
No Relationships to Disclose
 
Mark B. Pinkham
No Relationships to Disclose
 
Kenneth John O'Byrne
Stock and Other Ownership Interests - CARP Pharmaceuticals
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen-Cilag; Merck Sharp & Dohme; Mundipharma; Novartis; Pfizer/EMD Serono; Roche; Teva
Consulting or Advisory Role - AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen-Cilag; Merck Sharp & Dohme; Natera; Novartis; Pfizer; Roche/Genentech; Teva
Speakers' Bureau - Boehringer Ingelheim; Bristol-Myers Squibb; Foundation Medicine; Janssen-Cilag; Merck Sharp & Dohme; Mundipharma; Novartis; Pfizer; Roche
Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb
Patents, Royalties, Other Intellectual Property - I am named on 4 patents/provisional patents held by the University of Queensland (Inst)
Travel, Accommodations, Expenses - boehringer Ingelheim; Bristol-Myers Squibb; Roche
 
Rahul Ladwa
Honoraria - Ipsen; Merck; Roche
Consulting or Advisory Role - Merck Sharp & Dohme; Roche; Sanofi; Sun Pharma
Travel, Accommodations, Expenses - Ipsen; Roche; Sun Pharma